Leading the way to safer medication
 Crosscheck  Recommender

Apomorphine

Description

Apomorphine is a direct stimulant of dopamine receptors and while possessing both D1 and D2 receptor agonist properties does not share transport or metabolic pathways with levodopa. Its actions on parkinsonian motor disability are likely to be mediated at post-synaptic receptor sites.

ATC Classification

Code
Title
Category
G04BE07
Apomorphine
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
N04BC07
Apomorphine
N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists

Trade names

Trade name
Countries
APO-GO

Austria Cyprus Netherlands Spain United Kingdom

APOKINON

France

APOKYN

United States

APOMINE

Australia

DACEPTON

Austria Netherlands Spain United Kingdom

DOPACEPTIN

France

KYNMOBI

Canada United States

MOVAPO

Australia Canada

Product Monographs

Monograph
Type
Country
APO-go AMPOULES Solution for injection or infusion
MPI, EU: SmPC
UK
APO-GO Solution for injection
MPI, EU: SmPC
UK
KYNMOBI Sublingual film
MPI, US: SPL/PLR
US

2D Molecule Structure

3D Molecule Structure

Unique Ingredient Identifier (UNII)

N21FAR7B4S - APOMORPHINE

CAS Registry Number

41372-20-7 - Apomorphine

SNOMED-CT

387375001 - Apomorphine (substance)

 
Next: Usage >